FATE icon

Fate Therapeutics

180 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

16.67% less ownership

Funds ownership: 123.99%107.32% (-17%)

56% less capital invested

Capital invested by funds: $903M → $401M (-$502M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
180
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$116K
Puts
$48K
Net Calls
Net Calls Change

Top Buyers

1 +$4.48M
2 +$4.45M
3 +$4.42M
4
VPC
Vestal Point Capital
New York
+$3.94M
5
BBA
Baker Bros. Advisors
New York
+$3.87M

Top Sellers

1 -$18.8M
2 -$18.6M
3 -$11.6M
4
State Street
State Street
Massachusetts
-$8.85M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.51M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$43.2M
2
$34.7M
3
$33.2M
4
$26.9M
5
$18.3M
6
$17.5M
7
$15.9M
8
$14.7M
9
$13.4M
10
$11.7M
11
$11.1M
12
$10.3M
13
$9.83M
14
$8.45M
15
$7.7M
16
$7.37M
17
$6.99M
18
$6.59M
19
$6.56M
20
$6.51M
21
$5.56M
22
$5.1M
23
$5M
24
$4.45M
25
$3.39M